|
2026
|
P/S
|
Pharmaceutical preparations for human use |
|
|
Invention
|
Il2 agonists.
The invention relates to variants of interleukin-2 (IL2). In particular, the inven... |
|
|
Invention
|
Combination therapy for cancer treatment.
The invention relates to a combination of a binding ag... |
|
|
Invention
|
Combination therapy for cancer treatment. The present invention provides a combination of: (a) an... |
|
|
Invention
|
New uses of antibody-drug conjugates. The invention relates to an antibody-drug conjugate of form... |
|
|
Invention
|
Antibody-drug conjugates. 1233, L, Y, BM and q have the meanings defined herein, are provided. Pr... |
|
|
Invention
|
Vaccine compositions and methods of use. The present disclosure provides a therapy with vaccine c... |
|
|
Invention
|
Individualized vaccines for cancer.
The present invention is in the field of tumor immunotherapy... |
|
|
Invention
|
Psma binding molecule. The present invention relates to PSMA-binding binding molecules, polypepti... |
|
|
Invention
|
Fap binding molecule. The present invention relates to fibroblast activation protein alpha (FAP)-... |
|
|
Invention
|
Antibody drug conjugates. The invention relates to binding molecule-payload conjugates (BPCs), an... |
|
|
Invention
|
Compositions and methods. A composition comprising: (i) a cationically ionizable lipid; (ii) a st... |
|
|
Invention
|
Antibody drug conjugates comprising a binding molecule specific for stn. The invention relates to... |
|
|
Invention
|
Methods and compositions for determining immunoglobulin chain mispairing. The present disclosure ... |
|
|
Invention
|
Compositions for delivery of plasmodium antigens and related methods. The present disclosure prov... |
|
|
Invention
|
Cationic or ionizable lipids and uses thereof. The present disclosure provides a compound of form... |
|
|
Invention
|
Compounds. 123455, L, Y, BM and q have the meanings defined herein, are provided. Processes for p... |
|
|
Invention
|
Linkers for antibody drug conjugates. 6711, U, D, BM, and q have the meanings defined herein, are... |
|
|
Invention
|
Compositions for delivery of plasmodium rh5 antigens and related methods. The present disclosure ... |
|
|
Invention
|
Agents and methods for targeted delivery to cells. The invention relates to agents and methods fo... |
|
|
Invention
|
T cell receptor constructs and uses thereof. The present disclosure provides T cell receptors (TC... |
|
|
Invention
|
Technologies for determining tumor sample purity and/orgenomic characteristics using single nucle... |
|
|
Invention
|
Technologies for determining tumor sample purity and/or genomic characteristics. Presented herein... |
|
|
Invention
|
Technologies for mutation detection using tumor modeling and feedback. Presented herein are metho... |
|
|
Invention
|
Technologies for neoantigen prioritization based on tumor modeling and clonality states. Presente... |
|
|
Invention
|
Combination therapy comprising an rna cancer vaccine and a multispecific binding agent targeting ... |
|
2025
|
P/S
|
Pharmaceuticals for the treatment of cancer. |
|
|
P/S
|
Pharmaceutical products for the treatment of cancer |
|
|
P/S
|
Chemical agents for laboratory use, in particular nucleic acids, peptides and proteins; chemical ... |
|
|
Invention
|
Therapeutic rna for hpv-positive cancer. This disclosure relates to the field of therapeutic RNA ... |
|
|
Invention
|
Combination therapy comprising a multi-specific binding agent targeting pd-1/pd-l1 and vegf/vegfr... |
|
2024
|
Invention
|
Rna for preventing or treating tuberculosis.
The disclosure provides agents and methods for prev... |
|
|
Invention
|
Hiv vaccine.
The present invention concerns compositions comprising an RNA molecule, wherein the... |
|
|
Invention
|
Multispecific binding agents against pd-l1 and cd137 for treating cancer.
The present invention ... |
|
|
Invention
|
Fluid path system, mixing system, method for manufacturing a mixture, and use of a fluid path sys... |
|
|
Invention
|
Methods for predicting and improving therapeutic efficacy of cancer treatments and methods for ca... |
|
|
Invention
|
Stabilized nucleic acid compositions and methods for preparing, storing and using the same.
The ... |
|
|
Invention
|
Sting agonists containing hydrazide, hydrazine, and hydroxamic acid functional groups.
Compounds... |
|
|
Invention
|
Linker sequence potency assays for multiple coding nucleic acids.
The invention provides potency... |
|
|
P/S
|
Pharmaceutical preparations; vaccines. |
|
|
P/S
|
Pharmaceutical products for the treatment of cancer. |
|
|
P/S
|
Downloadable computer software used for biotechnology research and development; downloadable comp... |
|
|
P/S
|
Database management; data management; data processing; data management services; compilation of d... |
|
|
P/S
|
Computer software; computer software comprising algorithms for the selection of pharmaceutical re... |
|
|
P/S
|
Databases; database engines; data processing software; data management software; data mining soft... |
|
|
Invention
|
Fluid handling system and method.
A fluid handling system, comprising a fluid path system, the f... |
|
|
Invention
|
Compositions and methods.
An aqueous dispersion having an aqueous mobile phase and a dispersed p... |
|
|
Invention
|
Compositions and methods.
A method of forming an aqueous dispersion, the method comprising mixin... |
|
|
Invention
|
Pharmaceutical compositions for delivery of herpes simplex virus glycoprotein c, glycoprotein d, ... |
|
|
P/S
|
Pharmaceuticals for the treatment of cancer. |
|
|
P/S
|
Pharmaceuticals; vaccines. |
|
|
P/S
|
Pharmaceuticals for the treatment of cancer |
|
2023
|
Invention
|
Rna compositions targeting hiv.
The present disclosure provides compositions (e.g., pharmaceutic... |
|
|
Invention
|
Composition.
A composition comprising: (a) an active ingredient; and (b) a lipid mixture compris... |
|
|
P/S
|
Chemical products for medical and veterinary purposes;
medical and pharmaceutical preparations. ... |
|
|
P/S
|
Chemical preparations for medical and veterinary purposes, namely, for neuroregeneration and the ... |
|
|
Invention
|
Compositions for delivery of liver stage antigens and related methods.
The present disclosure pr... |
|
|
Invention
|
Multifunctional cells transiently expressing an immune receptor and one or more cytokines, their ... |
|
|
Invention
|
Humanised antibodies or functional fragments thereof against tumour antigens.
There is provided ... |
|
|
Invention
|
Binding agents capable of binding to cd27 in combination therapy.
The present invention provides... |
|
2022
|
Invention
|
Coronavirus vaccines and methods of use.
Compositions and methods for the prevention and/or trea... |
|
2018
|
Invention
|
Preparation and storage of liposomal rna formulations suitable for therapy. The present disclosur... |
